May 22, 2018 / 12:37 PM / in 5 months

BRIEF-Lilly's Taltz Receives U.S. FDA Approval For Label Update To Include Data For Psoriasis Involving The Genital Area

May 22 (Reuters) - Eli Lilly and Co:

* LILLY’S TALTZ (IXEKIZUMAB) RECEIVES THE FIRST U.S. FDA APPROVAL FOR LABEL UPDATE TO INCLUDE DATA FOR PSORIASIS INVOLVING THE GENITAL AREA

* LABEL UPDATE IS EFFECTIVE IMMEDIATELY IN UNITED STATES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below